Fluorocoxib A has been extensively studied both in vitro and in vivo for the detection of inflammation and cancer, demonstrating highly selective and specific uptake by COX-2-expressing tissues when compared to surrounding normal tissues [40, 41, 48, 69]. This evidence concerns the gene PTGS2 and cancer.